Navigation Links
MU College of Veterinary Medicine to study efficacy of cancer drug in dogs
Date:10/5/2010

COLUMBIA, Mo. A cancer drug that benefits people may soon benefit man's best friend.

Kim Selting, assistant teaching professor of oncology at the MU College of Veterinary Medicine, is the principal investigator in a study that examines the efficacy of Attaxol in dogs with naturally occurring cancer. Attaxol was developed, and is produced, by CritiTech, a Lawrence, Kan. drug development company.

Kim Selting, assistant teaching professor of oncology at the MU College of Veterinary Medicine.

"Cancer is one of the most common causes of death in dogs," Selting said. "This study is important because most chemotherapy drugs available to people can be used in dogs, except for the highly successful taxanes that can keep cancer from proliferating throughout the body. The Attaxol formulation is built specifically for dogs and could allow taxanes to be used by veterinarians."

MU veterinarians will conduct the clinical part of the study and assess cancer response in the dogs involved in the study. Data from an earlier safety study was used to establish a starting dose, and this second study will consist of an escalation phase to determine the optimal dose, followed by an extended treatment. CritiTech scientists will analyze blood samples to determine plasma levels of the drug during the course of treatment. Enrollment of dogs in the study is set to start in mid October, and it is anticipated that the study will take about two years to complete.

The Scott Endowed Program in Veterinary Oncology at MU is one of the largest veterinary oncology programs in the country and actively initiates and participates in clinical trials, as well as provides routine treatment of animals with cancer, including chemotherapy, cancer surgery and radiation therapy.

"We are excited about our continued collaboration with the University of Missouri College of Veterinary Medicine and the commercial opportunity to use CritiTech's fine-particle drug technology in the veterinary field," said Sam Campbell, CritiTech president and chairman.


'/>"/>

Contact: Steven Adams
AdamsST@missouri.edu
573-882-8353
University of Missouri-Columbia
Source:Eurekalert

Related biology news :

1. American College of Medical Genetics receives $13.5M NIH contract
2. Better beer: College team creating anticancer brew
3. College students find comfort in their pets during hard times
4. Texas College Police Unit Deploys BIO-key(R) Mobile Data System
5. High school students paper published in prestigious college math journal
6. NYU College of Dentistry awarded $1.9 million NIH grant for HIV research
7. Empire State Stem Cell Board awards $12.7 million to Albert Einstein College of Medicine
8. Imperial College London and NTU collaborate to offer joint Ph.D. programs in engineering and science
9. Boston College chemistry professor Udayan Mohanty receives a 2009 Guggenheim Fellowship
10. Genetic secrets of date palm unlocked by researchers at Weill Cornell Medical College in Qatar
11. American College of Medical Genetics affirms importance of newborn screening dried blood spots
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... -- IBM (NYSE: IBM ) is introducing several innovative partner ... developing collaboration between startups and global businesses, taking place in ... event, nine startups will showcase the solutions they have built ... France is one of ... 30 percent increase in the number of startups created between ...
(Date:4/24/2017)... WASHINGTON , April 24, 2017 ... counsel and partner with  Identity Strategy Partners, LLP ... "With or without President Trump,s March 6, ... Foreign Terrorist Entry , refugee vetting can be instilled ... refugee resettlement. (Right now, all refugee applications are ...
(Date:4/13/2017)... , April 13, 2017 According to a ... Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment ... the IAM Market is expected to grow from USD 14.30 Billion in ... Rate (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... SANTA CRUZ, Calif. , Oct. 10, 2017 /PRNewswire/ ... SBIR grant from the NIH to develop RealSeq®-SC (Single ... preparation kit for profiling small RNAs (including microRNAs) from ... Cell Analysis Program highlights the need to accelerate development ... "New techniques for ...
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving Tree Wellness ... targeting the needs of consumers who are incorporating medical marijuana into their wellness ... Arizona. , As operators of two successful Valley dispensaries, The Giving Tree’s two ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the ... and accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using their ...
Breaking Biology Technology: